Strategy
Before Clinical Proof of Concept
We partner with companies that have development candidates, translating their preclinical science into early human safety and efficiency data.
Platforms
We believe there lies opportunity in multi-product platforms. Complex questions of growth, strategy and value creation are front and center, and offer asymmetric upside.